[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=2f0287c52d508f4794769d49cc114ba5c81aa94d07660f0013e6fa81c1420d1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750338003,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 135396993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=2f0287c52d508f4794769d49cc114ba5c81aa94d07660f0013e6fa81c1420d1c"
    }
  },
  {
    "ts": null,
    "headline": "Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?",
    "summary": "CRSP bets on Casgevy to drive growth, but its extremely high price tag and slow rollout test investor patience in a crowded field.",
    "url": "https://finnhub.io/api/news?id=da9191f86dda5a7c2f6de2534b005caee6a09e8274c33fa1eecede7897a71846",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750332120,
      "headline": "Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?",
      "id": 135389639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "CRSP bets on Casgevy to drive growth, but its extremely high price tag and slow rollout test investor patience in a crowded field.",
      "url": "https://finnhub.io/api/news?id=da9191f86dda5a7c2f6de2534b005caee6a09e8274c33fa1eecede7897a71846"
    }
  },
  {
    "ts": null,
    "headline": "2 Growth Stocks to Buy and Hold for 10 Years",
    "summary": "A decade after its IPO, Shopify still has the qualities that allowed it to deliver significantly above average returns.  Despite recent issues, Vertex Pharmaceuticals' innovative lineup and pipeline should lead to strong performances.",
    "url": "https://finnhub.io/api/news?id=880b17b636c406ac89a2abafe0d4494cadf32ea6dcf1482039d490a11db3ecaa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750321500,
      "headline": "2 Growth Stocks to Buy and Hold for 10 Years",
      "id": 135389640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "A decade after its IPO, Shopify still has the qualities that allowed it to deliver significantly above average returns.  Despite recent issues, Vertex Pharmaceuticals' innovative lineup and pipeline should lead to strong performances.",
      "url": "https://finnhub.io/api/news?id=880b17b636c406ac89a2abafe0d4494cadf32ea6dcf1482039d490a11db3ecaa"
    }
  }
]